In addition, altered microtubule dynamics, due to changes in the expression or post-translational modifications of microtubule-associated proteins (MAPs), may contribute to tumor resistance to PTX in a wide range of cancer types (Safinya et al. 2016; Orr et al. 2003; Xie et al. 2016). This evidence concerns the gene C3orf62 and neoplasm.